6 November 2023 - The European Federation of Pharmaceutical Industries and Associations (EFPIA) is publishing new research which assesses the ...
4 April 2023 - The EMA is introducing a number of new features to the PRIority Medicines (PRIME) scheme to ...
2 March 2023 - Real world data are advocated as an alternative approach to randomised clinical trials for closing knowledge gaps ...
25 August 2022 - Officials from the EMA tout the benefits of patient registries to support regulatory decision making for ...
24 May 2022 - As part of its efforts to support a global approach to the development of new antimicrobial medicines, ...
2 February 2022 - Coalition urges reformation of EU wide drug research and development to drive treatment optimisation ...
21 January 2022 - International regulators have published a report today highlighting their discussions on the effectiveness of current vaccines against ...
11 December 2021 - EMA has endorsed a statement by the International Coalition of Medicines Regulatory Authorities that urges all ...
28 October 2021 - EMA and the Heads of Medicines Agencies are launching a pilot project to support the repurposing ...
16 July 2021 - Regulatory convergence is critical for expediting and streamlining global development and authorisation of new or modified COVID-19 ...
28 June 2021 - EMA has issued an update of the EU recommendations for the influenza virus strains that vaccine ...
28 June 2021 - EMA has published today a report highlighting the Agency’s support for micro, small and medium sized ...
25 February 2021 - EMA has issued guidance outlining the requirements for manufacturers planning to modify their COVID-19 vaccines in ...
2 February 2021 - The European Medicines Agency has released a draft guidance to assist drug developers using its Priority ...
23 November 2020 - On Monday, 30 November, EMA is hosting a workshop to discuss the benefits and impact of ...